Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models.
- Published in:
- Oncogene, 2008, v. 27, n. 1, p. 85, doi. 10.1038/sj.onc.1210623
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 2008 AND VI 27 AND IP 1
Results: 16
1
2
A high-throughput screening for mammalian cell death effectors identifies the mitochondrial phosphate carrier as a regulator of cytochrome c release.
- Published in:
- Oncogene, 2008, v. 27, n. 1, p. 44, doi. 10.1038/sj.onc.1210600
- By:
- Publication type:
- Article
3
Proliferation-associated Brn-3b transcription factor can activate cyclin D1 expression in neuroblastoma and breast cancer cells.
- Published in:
- Oncogene, 2008, v. 27, n. 1, p. 145, doi. 10.1038/sj.onc.1210621
- By:
- Publication type:
- Article
4
Distinct BRCT domains in Mcph1/Brit1 mediate ionizing radiation-induced focus formation and centrosomal localization.
- Published in:
- Oncogene, 2008, v. 27, n. 1, p. 139, doi. 10.1038/sj.onc.1210595
- By:
- Publication type:
- Article
5
The intestine-specific homeobox gene Cdx2 decreases mobility and antagonizes dissemination of colon cancer cells.
- Published in:
- Oncogene, 2008, v. 27, n. 1, p. 107, doi. 10.1038/sj.onc.1210601
- By:
- Publication type:
- Article
6
Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiation.
- Published in:
- Oncogene, 2008, v. 27, n. 1, p. 126, doi. 10.1038/sj.onc.1210622
- By:
- Publication type:
- Article
7
Downregulation of c-FLIP promotes caspase-dependent JNK activation and reactive oxygen species accumulation in tumor cells.
- Published in:
- Oncogene, 2008, v. 27, n. 1, p. 76, doi. 10.1038/sj.onc.1210624
- By:
- Publication type:
- Article
8
Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells.
- Published in:
- Oncogene, 2008, v. 27, n. 1, p. 9, doi. 10.1038/sj.onc.1210626
- By:
- Publication type:
- Article
9
Kruppel-like factor 5 modulates p53-independent apoptosis through Pim1 survival kinase in cancer cells.
- Published in:
- Oncogene, 2008, v. 27, n. 1, p. 1, doi. 10.1038/sj.onc.1210625
- By:
- Publication type:
- Article
10
TACC3 depletion sensitizes to paclitaxel-induced cell death and overrides p21<sup>WAF</sup>-mediated cell cycle arrest.
- Published in:
- Oncogene, 2008, v. 27, n. 1, p. 116, doi. 10.1038/sj.onc.1210628
- By:
- Publication type:
- Article
11
Egr-1 abrogates the E2F-1 block in terminal myeloid differentiation and suppresses leukemia.
- Published in:
- Oncogene, 2008, v. 27, n. 1, p. 98, doi. 10.1038/sj.onc.1210627
- By:
- Publication type:
- Article
12
Inhibition of thromboxane synthase activity modulates bladder cancer cell responses to chemotherapeutic agents.
- Published in:
- Oncogene, 2008, v. 27, n. 1, p. 55, doi. 10.1038/sj.onc.1210629
- By:
- Publication type:
- Article
13
Molecular mimicry in inducing DNA damage between HIV-1 Vpr and the anticancer agent, cisplatin.
- Published in:
- Oncogene, 2008, v. 27, n. 1, p. 32, doi. 10.1038/sj.onc.1210632
- By:
- Publication type:
- Article
14
Regulation of normal cell cycle progression by flavin-containing oxidases.
- Published in:
- Oncogene, 2008, v. 27, n. 1, p. 20, doi. 10.1038/sj.onc.1210634
- By:
- Publication type:
- Article
15
POU2AF1, an amplification target at 11q23, promotes growth of multiple myeloma cells by directly regulating expression of a B-cell maturation factor, TNFRSF17.
- Published in:
- Oncogene, 2008, v. 27, n. 1, p. 63, doi. 10.1038/sj.onc.1210637
- By:
- Publication type:
- Article
16
Protein kinase WNK2 inhibits cell proliferation by negatively modulating the activation of MEK1/ERK1/2.
- Published in:
- 2008
- By:
- Publication type:
- Correction Notice